Mohammad HASHEMI, Hamzeh REZAEI, Ebrahim ESKANDARI-NASAB

Association between the apelin rs2235306 gene polymorphism and metabolic syndrome

The rs2235306 of apelin polymorphism has been shown to be associated with fasting plasma glucose levels and hypertension. The present study aimed to investigate the impact of the apelin rs2235306 gene polymorphism on the risk of metabolic syndrome (MeS) in a sample of the Iranian population. Materials and methods: This population-based cross-sectional study was performed on 151 subjects with MeS and 149 without MeS, as defined by ATPIII criteria. Apelin rs2235306 polymorphism detection was done using the tetra amplification refractory mutation system-polymerase chain reaction. Because the apelin gene is located on the X chromosome, statistical analyses were conducted in a sex-specific manner. Results: Our findings proposed that the apelin rs2235306 polymorphism was not associated with MeS susceptibility in the codominant, dominant, and recessive inheritance models tested (OR = 0.93, 95% CI = 0.51-1.71 for TC vs. TT; OR = 2.39, 95% CI = 0.70-8.16 CC vs. TT; OR = 1.09, 95% CI = 0.62-1.93 for TC+CC vs. TT; and OR = 2.45, 95% CI = 0.73-8.21 for CC vs. TT+TC). We found that the apelin TC+CC genotypes were associated with lower HDL-cholesterol in women without MeS. Conclusion: Our findings indicated no association between the apelin rs2235306 polymorphism and MeS. However, the results suggest that healthy females carrying apelin TC+CC genotypes have lower HDL-cholesterol in comparison with those carrying TT, which remains to be confirmed.

Anahtar Kelimeler:

Metabolic syndrome, apelin, polymorphism

Association between the apelin rs2235306 gene polymorphism and metabolic syndrome

Keywords:

Metabolic syndrome, apelin, polymorphism,

PDF

___

Kaykhaei MA, Hashemi M, Narouie B, Shikhzadeh A, Jahantigh M, Shirzaei E, Rezazehi B, Hoseinian M, Yousefi S, Masoudian S et al. Prevalence of metabolic syndrome in adult population from Zahedan, southeast Iran. Iran J Public Health 2012; 41: 70–76.
Aydın S, Gemalmaz A, Nayir T, Özkan Ş. Which predicts the cardiovascular risk best in elderly metabolic syndrome patients: ATP III or IDF? Turk J Med Sci 2011; 14: 125–129.
Azimi-Nezhad M, Herbeth B, Siest G, Dade S, Ndiaye NC, Esmaily H, Hosseini SJ, Ghayour-Mobarhan M, Visvikis- Siest S. High prevalence of metabolic syndrome in Iran in comparison with France: what are the components that explain this? Metab Syndr Relat Disord 2012; 10: 181–188.
Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005; 165: 2644–2650.
Sobti RC, Kler R, Sharma YP, Talwar KK, Singh N. Risk of obesity and type 2 diabetes with tumor necrosis factor-alpha 308G/A gene polymorphism in metabolic syndrome and coronary artery disease subjects. Mol Cell Biochem 2012; 360: 1–7.
Gupta V, Gupta A, Jafar T, Gupta V, Agrawal S, Srivastava N, Kumar S, Singh AK, Natu SM, Agarwal CG et al. Association of TNF-alpha promoter gene G-308A polymorphism with metabolic syndrome, insulin resistance, serum TNF-alpha and leptin levels in Indian adult women. Cytokine 2012; 57: 32–36.
Zhou D, Liu H, Zhou M, Wang S, Zhang J, Liao L, He F. Common variant (rs9939609) in the FTO gene is associated with metabolic syndrome. Mol Biol Rep 2012; 39: 6555–6561.
Xi B, Ruiter R, Chen J, Pan H, Wang Y, Mi J. The ACE insertion/ deletion polymorphism and its association with metabolic syndrome. Metabolism 2012; 61: 891–897.
Değer O, Yandı YE, Ayvaz M, Erem C, Hacıhasanoğlu AB. Polymorphisms in ABC transporters (ABCA1 and ABCC8) in metabolic syndrome. Turk J Med Sci 2013; 43: 214–221.
Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, Kawamata Y, Fukusumi S, Hinuma S, Kitada C et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998; 251: 471–476.
Japp AG, Newby DE. The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential. Biochem Pharmacol 2008; 75: 1882–1892.
Charles CJ. Putative role for apelin in pressure/volume homeostasis and cardiovascular disease. Cardiovasc Hematol Agents Med Chem 2007; 5: 1–10.
Cekmez F, Canpolat FE, Pirgon O, Çetinkaya M, Aydinoz S, Suleymanoglu S, Ipcioglu OM, Sarici SU. Apelin, vaspin, visfatin and adiponectin in large for gestational age infants with insulin resistance. Cytokine 2011; 56: 387–391.
Liao YC, Chou WW, Li YN, Chuang SC, Lin WY, Lakkakula BV, Yu ML, Juo SH. Apelin gene polymorphism influences apelin expression and obesity phenotypes in Chinese women. Am J Clin Nutr 2011; 94: 921–928.
Niu W, Wu S, Zhang Y, Li W, Ji K, Gao P, Zhu D. Validation of genetic association in apelin-AGTRL1 system with hypertension in a larger Han Chinese population. J Hypertens 2010; 28: 1854–1861.
Li WW, Niu WQ, Zhang Y, Wu S, Gao PJ, Zhu DL. Family- based analysis of apelin and AGTRL1 gene polymorphisms with hypertension in Han Chinese. J Hypertens 2009; 27: 1194–1201.
Zhao Q, Hixson JE, Rao DC, Gu D, Jaquish CE, Rice T, Shimmin LC, Chen J, Cao J, Kelly TN et al. Genetic variants in the apelin system and blood pressure responses to dietary sodium interventions: a family-based association study. J Hypertens 2010; 28: 756–763.
Zhang R, Lu J, Hu C, Wang C, Yu W, Jiang F, Tang S, Bao Y, Xiang K, Jia W. Associations of common variants at APLN and hypertension in Chinese subjects with and without diabetes. Exp Diabetes Res 2012; 2012: 917496.
Zhang R, Hu C, Wang CR, Ma XJ, Bao YQ, Xu J, Lu JY, Qin W, Xiang KS, Jia WP. Association of apelin genetic variants with type 2 diabetes and related clinical features in Chinese Hans. Chin Med J (Engl) 2009; 122: 1273–1276.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
Hashemi M, Moazeni-Roodi AK, Fazaeli A, Sandoughi M, Bardestani GR, Kordi-Tamandani DM, Ghavami S. Lack of association between paraoxonase-1 Q192R polymorphism and rheumatoid arthritis in southeast Iran. Genet Mol Res 2010; 9: 333–339.
Hashemi M, Moazeni-Roodi A, Bahari A, Taheri M. A tetra- primer amplification refractory mutation system-polymerase chain reaction for the detection of rs8099917 IL28B genotype. Nucleosides Nucleotides Nucleic Acids 2012; 31: 55–60.
Hashemi M, Hoseini H, Yaghmaei P, Moazeni-Roodi A, Bahari A, Hashemzehi N, Shafieipour S. Association of polymorphisms in glutamate-cysteine ligase catalytic subunit and microsomal triglyceride transfer protein genes with nonalcoholic fatty liver disease. DNA Cell Biol 2011; 30: 569–575.
Zhang L, Dai Y, Bian L, Wang W, Wang W, Muramatsu M, Hua Q. Association of the cell death-inducing DNA fragmentation factor alpha-like effector A (CIDEA) gene V115F (G/T) polymorphism with phenotypes of metabolic syndrome in a Chinese population. Diabetes Res Clin Pract 2011; 91: 233– 238.
Hahsemi M, Rezaei H, Eskandari Nasab E, Kaykhaei MA, Zakeri Z, Taheri M. Association between chemerin rs17173608 and vaspin rs2236242 gene polymorphisms and the metabolic syndrome, a preliminary report. Gene 2012; 510: 113–117.
Zhao Q, Gu D, Kelly TN, Hixson JE, Rao DC, Jaquish CE, Chen J, Huang J, Chen CS, Gu CC et al. Association of genetic variants in the apelin-APJ system and ACE2 with blood pressure responses to potassium supplementation: the GenSalt study. Am J Hypertens 2010; 23: 606–613.